Consolidated figures · ₹ crore
| ₹ Cr | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| 174 | 190 | 222 | 216 | 224 | |
| COGS | 11 | 24 | 24 | 25 | 26 |
| Gross profit | 163 | 166 | 197 | 191 | 199 |
| 84 | 74 | 97 | 113 | 107 | |
| 79 | 92 | 101 | 78 | 92 | |
| OPM % | 45.2% | 48.5% | 45.4% | 36.2% | 41% |
| Depreciation | 10 | 10 | 11 | 16 | 15 |
| Interest | 2 | 4 | 3 | 4 | 3 |
| 1 | 1 | 3 | 3 | 14 | |
| Profit before tax | 69 | 79 | 89 | 61 | 88 |
| Tax | 17 | 20 | 22 | 16 | 22 |
| Tax % | 25.2% | 25.4% | 25.1% | 26.4% | 24.7% |
| 51 | 59 | 67 | 45 | 66 | |
| PAT margin % | 29.4% | 31% | 30% | 20.9% | 29.4% |
| EPS (₹) | 4.1 | 4.7 | 5.4 | 3.6 | 5.3 |
| Results filing | — | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue YoY % | — | — | — | — | +28.8% |
| PAT YoY % | — | — | — | — | +28.5% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Ayurvedic products/ medicines | 118.28 | 41.24 | 0 | 0 |
| Ayurvedic healthcare services | 104.75 | 42.71 | 0 | 0 |
| Others | 1.38 |
| 1.38 |
| 0 |
| 0 |
₹ crore by quarter